Manufacturing and Production

Showing 15 posts of 5860 posts found.

clinical_study

Genfit’s NASH drug fails Phase 3 clinical trial

May 12, 2020 Manufacturing and Production FDA, nash

The Phase 3 trial for Genfit’s drug elafibranor has failed to improve outcomes for patients with the fatty liver disease …
fda

FDA provides new guidelines to accelerate the development of COVID-19 treatments

May 12, 2020 Manufacturing and Production COVID-19, FDA, coronavirus, pandemic

The FDA has provided new guidelines to researchers studying potential COVID-19 treatments to help speed up the process of their …
jonathanfreve

Jonathan Freve joins Galecto as Chief Financial Officer

May 5, 2020 Manufacturing and Production

The biotech company Galecto Inc have appointed Jonathan Freve as its Chief Financial Officer, and in his role he will …
france-3370174_1280

First French case of COVID-19 occurred in December, a month earlier than previously thought

May 5, 2020 Manufacturing and Production COVID-19, coronavirus

A French patient who suffered from pneumonia in December actually had COVID-19, it has been revealed. Dr Yves Cohen, the …
Malaria treatment in Angola

Scientists in Kenya discover microbe that could stop transmission of malaria

May 5, 2020 Manufacturing and Production malaria, mosquitoes

Researchers studying malaria in Kenya have discovered a microbe that blocks transmission of malaria from mosquitoes which could pave the …
s300_yellow-card-govuk960

MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments

May 5, 2020 Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma

A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
isle_of_wight

UK contact-tracing app being tested on the Isle of Wight

May 5, 2020 Manufacturing and Production COVID-19, coronavirus

The NHS’s coronavirus contract tracing app has been published to Apple and Google’s app stores with council staff and healthcare …
shutter

Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer

May 5, 2020 Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi

Sanofi and Regeneron’s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …
kim_stratton_orphazyme

Working Life Interview: Kim Stratton, CEO, Orphazyme

May 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life

“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …
512px-oxford_university_colleges-all_souls1

AstraZeneca joins forces with University of Oxford to develop and manufacture potential coronavirus vaccine

April 30, 2020 Manufacturing and Production, Research and Development AstraZeneca, COVID-19, University of Oxford, coronavirus, pharma

A “landmark” partnership has been struck between AstraZeneca and the University of Oxford in the ongoing battle against COVID-19, with …

Nearly half of Americans believe COVID-19 was created in a lab, according to a new survey

April 28, 2020 Manufacturing and Production COVID-19, coronavirus, survey

Almost half of Americans believe that the coronavirus was created in a lab, according to an April survey of 6,300 …
janssen_latest_logo_on_sign_closer

NICE backtracks to approve Janssen’s Stelara in ulcerative colitis

April 28, 2020 Manufacturing and Production, Research and Development Janssen, NICE, Stelara, ulcerative colitis

NICE has recommended Janssen’s Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis (UC), a move which …
The Gateway to Local Adoption Series

Latest content